Healing Lyme: The Neuroinflammation-Brain Protection Summit - Day 2
How Big Data and New Research Are Transforming Lyme Treatment
Healing Lyme: The Neuroinflammation-Brain Protection Summit Playlist
The Neuroinflammation Map: How Different Brain Regions Drive Symptoms
Myriah Hinchey, ND, FMAPS
LymeBytes! Symposium, November 13-14, 2026 Fort Lauderdale, FL
Myriah Hinchey, ND, FMAPS
Zeolite: The Detox Strategy That Changes Everything for Chronic Illness
Jeff Hoyt
Preview
Why You’re Not Healing Properly: The Cell Danger Response Explained
Melanie Stein, ND
How Lyme Disease Inflames Your Brain—And What to Do About It
Myriah Hinchey, ND, FMAPS
The Hidden Link Between Chronic Lyme and Dementia
Richard Horowitz, MD
Preview
How Big Data and New Research Are Transforming Lyme Treatment
Sarah Quillen, MPA, CFRE
Preview
Precision Medicine Approach To Alzheimer’s
Dale Bredesen, MD
Preview
The Hidden Link Between Lyme Disease and Multiple Sclerosis
Terry Wahls, MD
Preview
Unraveling Chronic Lyme’s Multiple Causes
Nafysa Parpia, ND
Can Lyme Disease Influence Alzheimer’s Biomarkers? A First Live Case Study
Richard Horowitz, MD
Your Guide to Immediate Tick Bite Response
Myriah Hinchey, ND, FMAPS
What is Herx and How to Manage It
Myriah Hinchey, ND, FMAPS
The Doctor-Formulated Herbal Approach to Lyme Support
Myriah Hinchey, ND, FMAPS
Guaranteed safe & secure checkout
All Access Pass to all DrTalks Summits. Includes over 2,243+ health-altering interviews from real doctors and health experts, with 75+ added every month. Renews annually at $97/year. Cancel any time
UNLOCK INSTANT ACCESS1 month ago
- Discover how ILADS is revolutionizing Lyme disease education, training thousands of clinicians, and funding new research to improve patient outcomes.
- Learn why chronic Lyme and co-infections are often overlooked in mainstream medicine—and how a new fellowship program is changing that.
- Uncover how big data, AI, and cutting-edge research are driving the future of Lyme disease treatment and why this could mean faster diagnoses for millions.
Comments